Actively Recruiting
A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients
Led by CSPC Ouyi Pharmaceutical Co., Ltd. · Updated on 2024-07-22
144
Participants Needed
1
Research Sites
70 weeks
Total Duration
On this page
Sponsors
C
CSPC Ouyi Pharmaceutical Co., Ltd.
Lead Sponsor
Z
Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
A 52-Week Study of SYHX1901 tablet in Adults with non-segmental vitiligo.
CONDITIONS
Official Title
A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to sign an informed consent form and able to follow study procedures
- Male or female between 18 and 65 years old
- Diagnosed with non-segmental vitiligo
- Agree to stop all other vitiligo treatments during the study
- Women of child-bearing potential must have a negative pregnancy test within 3 days before first dose
You will not qualify if you...
- Diagnosed with other active depigmentation diseases
- Active inflammatory skin disease or symptoms interfering with vitiligo evaluation
- Uncontrolled thyroid function at screening
- Use of permanent depigmentation treatments or skin grafts
- Use of phototherapy or topical/systemic treatments within a specified time before Day 1
- Active infections requiring medical treatment
- Progressive or uncontrolled systemic or chronic diseases deemed unsuitable by investigators
- History of alcohol or drug abuse within 1 year prior to screening
- History of neurological or mental disorders such as severe depression, suicidal tendencies, epilepsy, or dementia
- Any other reasons determined by the investigator as making the subject ineligible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical Trials Information Group
Shijiazhuang, China
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here